Tilray Medical, a recognized global leader in medical cannabis and a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), today announced its largest portfolio expansion in Australia ...
By Sriparna Roy March 16 (Reuters) - Cannabis-based medicines have shown little evidence of effectiveness for treating most ...
ScienceAlert on MSN
Large Medical Cannabis Review Finds Scarce Evidence It Treats Mental Health Disorders
(Anastassiya Bezhekeneva/Getty Images) A large umbrella review has found no strong evidence to date that medicinal cannabis ...
Increasing numbers of Australians are using medicinal cannabis for anxiety, depression, insomnia, substance disorders and ...
EDMONTON, AB, June 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has expanded their popular IndiMed brand with the ...
There’s “no evidence” that medical marijuana is effective in treating anxiety, depression or post-traumatic stress, according ...
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the ...
International researchers find ‘very little evidence’ medical form of the drug can treat anxiety, anorexia and other disorders ...
Years in the making, the Canadian LP is finding markets closer to the pharmaceutical industry in highly regulated medical cannabis markets.
Chief Financial Officer Simona King outlined the company’s recent strategic pivot toward medical cannabis and international expansion during a fireside chat at the TD Cowen Healthcare Conference, ...
Employees sacked by Australia’s biggest medicinal cannabis company say its medical affairs team has been gutted, raising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results